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Summary
Background: The adequacy of the World Health Organization’s syndromic approach for the
diagnosis and management of sexually transmitted diseases (STDs), especially at primary health
centers (PHCs) and at other levels, is still debatable in different settings in India and requires
validation.
Objectives: A cross-sectional study was carried out in women attending the peripheral govern-
ment clinics of Delhi in order to (1) enumerate their self-reported reproductive tract infection
(RTI)/sexually transmitted infection (STI) symptoms; (2) assess their clinical status; (3) determine
the syndromic diagnosis of RTI/STI in symptomatic women and etiological diagnosis in both
symptomatic and asymptomatic women; and (4) compare the level of agreement between self-
reporting of morbidity and syndromic and etiological diagnosis.
Materials and methods: The study was conducted over 26 months in 4090 women attending
peripheral government healthcare centers, both rural and urban, in four zones of Delhi. They
were recruited into four different study groups: group I, non-pregnant, reporting with symptoms
of RTI/STI; group II, with a bad obstetric history or infertility; group III, pregnant women in any
trimester attending the antenatal clinic; and group IV, the control group. Gynecological exam-
ination, followed by the collection of genital specimens and blood, were performed after
informed and written consent was obtained. Every symptomatic patient was managed on the
basis of algorithms of the syndromic approach as recommended by the National AIDS Control
Organisation (NACO), India. All specimens were transported to the STD Reference Laboratory,
Safdarjung Hospital, New Delhi and processed by standard methods to diagnose the various STDs.
* Corresponding author. Tel.: +91 11 26125080; fax: +91 11 26163072.
E-mail address: drkray@yahoo.com (K. Ray).
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Laboratory reports were sent to the clinicians and appropriate treatment was instituted. Data
were analyzed by applying statistical methods.
Results: Overall, self-reporting of morbidity was 65.0%. However, the percentage of women with
some STD-related syndromewas 71.4%. The rural womenwere observed to have significantly more
STD syndromes than their urban counterparts. The etiological diagnosis could be established in
only 32.2% of cases.
Conclusions: This study highlights the wide variation between self-reporting of morbidity and
syndromic- and etiology-based diagnosis in women from both rural and urban settings. This has
implications for the syndromic approach to STI case management. These observations call for a
review of the diagnostic policy for RTIs/STIs by national authorities in order to avoid the overuse of
antimicrobials. The study also highlights the need for the introduction and/or strengthening of
facilities for simple diagnostic tests for RTIs/STIs, especially at the peripheral healthcare level.
# 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Globally, sexually transmitted infections (STIs) constitute a
major public health problem. Over 300 million new cases are
reported annually and 75—85% of them are in developing
countries.1 In India too, ulcerative and non-ulcerative STIs
have emerged as important public health concerns,2—4 with
increasing gynecological morbidity and mortality in women.4
Disability adjusted life years (DALYs) lost per annum are
greater for women than men.5
This subject was not given its due importance until the
advent of the HIV/AIDS era, when the spotlight shifted onto
STIs due to their proven role in the facilitation of HIV infec-
tion.6 The main methods of prevention and control of HIV
infection in the absence of a safe and effective vaccine, are
the promotion of safe sex and the treatment of STIs.7,8
Recent data highlight the importance of bacterial vaginosis
(BV) as a cofactor in HIV infection.9 In developing countries,
like India, symptoms of STIs and reproductive tract infections
(RTIs), like vaginal discharge and ulcers, should be reported
by the women themselves. However, it is noticeable that very
often they do not report to healthcare facilities due to
various impediments such as their low status in society,
illiteracy, ignorance, and rigid social norms. To compound
this, there is the inherent problem of STIs remaining asymp-
tomatic.10 The above factors have resulted in poor avail-
ability of data on RTIs/STIs, both symptomatic and
asymptomatic, among women.
Women who do report to a healthcare facility for any RTI/
STI symptom are usually managed by the syndromic approach
of the World Health Organization (WHO). This approach has
been recommended by NACO, India,11 at the primary health
center (PHC) level,2 as it is feasible, adaptable, and cost-
effective. Syndromic diagnosis is mostly carried out without
offering any laboratory-based diagnosis, because of the high
costs involved and the lack of facilities countrywide. How-
ever, a community study in women who self-reported mor-
bidity, supported by laboratory diagnosis, could not establish
consistency in the two methods.12 Other studies have also
been unable to fully validate the efficacy of this strategy.13,14
In addition, data on asymptomatic carriage of these infec-
tions by women are almost non-existent, thereby hindering
treatment.
This study was carried out in women attending both rural
and urban clinics in the outskirts of Delhi, India, with the
objectives of: (1) enumerating their self-reported RTI/STIsymptoms; (2) assessing the clinical status by vaginal, biman-
ual, and speculum examination; (3) determining the syndro-
mic diagnosis of RTIs/STIs in symptomatic women and the
microbiological diagnosis in both symptomatic and asympto-
matic women; and (4) comparing the level of agreement
between self-reporting of morbidity and syndromic and etio-
logical diagnosis in the symptomatic women in the different
groups.
Materials and methods
The study was carried out at the Regional STD Teaching,
Training and Research Centre, Vardhman Mahavir Medical
College and Safdarjung Hospital, New Delhi, over a period
of 26 months, between March 2002 and April 2004. Institu-
tional ethics committee approval was obtained prior to the
commencement of the study.
Study population
The study population was recruited from different urban and
rural health clinics in the National Capital Territory (NCT) of
Delhi, having a population of approximately 10 million. Two
government health set-ups, one urban and one rural, each
from four zones — East, West, North, and South — were
identified. A total of 4090 consecutive women (2079 from
urban and 2011 from rural dispensaries), in the age range of
14—70 years, were recruited and assigned to one of the four
study groups.
Women aged between 14 and 70 years, who were willing
and able to provide informed consent to take part in the
study, and who had symptoms unrelated to those of men-
struation, either using/not using some method of contra-
ception, were included. Group I consisted of a total of 1105
non-pregnant women (558 from urban and 547 from rural
dispensaries), with symptoms of current vaginal discharge/
genital ulcer/other. Group II comprised 621 women (317 from
urban and 304 from rural dispensaries), who were high-risk
cases with a bad obstetric history (two or more abortions/
intrauterine growth retardation/stillbirth or neonatal death,
and/or infertility (primary or secondary)). Group III consisted
of 1563 pregnant women (790 from urban and 773 from rural
areas) in any trimester, attending antenatal clinics. Group IV
comprised 801 non-pregnant women (414 from urban and 387
from rural areas) recruited by consecutive sampling, with
problems other than RTIs/STIs, attending gynecology (for
e354 K. Ray et al.uterine prolapse, fibroids), surgical, and medical clinics. This
group was studied in order to determine the presence of
syndromes as well as etiological agents of RTIs/STIs in asymp-
tomatic women.
Women with other infections, such as urinary tract infec-
tions (UTIs), an irregular menstrual history, other menstrual
problems, or gynecological surgeries were excluded from the
study.
Data regarding literacy level, use of contraceptives, his-
tory of RTIs/STIs, knowledge and awareness of HIV/AIDS/
STIs, healthcare-seeking behavior, etc., were collected and
collectively recorded in a proforma (questionnaire) designed
for this purpose (details presented in a separate communica-
tion15). Before sending patients to the doctor, pre-test coun-
seling and health education were imparted by a trained social
worker using the conventional techniques. Informed written
consent was obtained from all patients before participation
in the study, and full confidentiality was assured. Each study
recruit was assigned a code number for future reference.
Physical examination (vaginal, speculum, and bimanual)
was carried out, to assess the presence of any abnormal
discharge, genital ulcers, genital warts, cervicitis, cervical
erosion, pelvic inflammatory diseases (PID), prolapse, etc.
Cervical, vaginal, and urethral swabs and blood samples were
collected for laboratory investigations. Swabs from ulcers
(when present) were collected. Specimens were also col-
lected from the asymptomatic patients included in the other
study groups and the controls. All samples were transported
immediately to the Regional STD Reference Laboratory of the
Regional STD Teaching, Training and Research Centre, Vardh-
man Mahavir Medical College and Safdarjung Hospital, New
Delhi in transport media, wherever applicable, and pro-
cessed on the same day. Swabs for Chlamydia trachomatis
antigen detection in special transport medium (supplied with
the kit) were stored at 70 8C until use. The tests were
carried out as per standard techniques as detailed below.16
Laboratory techniques
The following tests were carried out in all the study group
subjects: (1) venereal disease research laboratory (VDRL;
antigen from the Serologist to Kolkata, Government of India)
and Treponema pallidum hemagglutination assay (TPHA;
Plasmatec TPHA test kit, Hansard Diagnostics, UK) in VDRL
reactive sera, for syphilis; (2) direct urethral/cervical smear
and culture on chocolate agar and saponin-lysed blood agar
with vancomycin, colistin, nystatin, trimethoprim (VCNT)
supplement to detect Neisseria gonorrhoeae and confirma-
tion of the isolates by standard methods;17 (3) ELISA (Bio-Rad
Laboratories, WA, USA) for detection of chlamydial antigen
(Chlamydia trachomatis); (4) direct wet mount examination
and culture on Kupferberg broth with Trichomonas vaginalis
supplement for the detection of T. vaginalis; (5) direct Gram-
stained smear examination and culture on Sabouraud’s dex-
trose agar, followed by culture confirmation by germ tube
test for the detection of Candida albicans and other Candida
species; (6) examination and interpretation of vaginal Gram-
stained smear following Nugent’s scoring18 for the diagnosis
of BV; (7) herpes simplex virus-2 (HSV-2) IgM antibodies by
ELISA (Equipar diagnostic kit, Italy) for detecting herpes
progenitalis infection. Genital warts were clinically diag-
nosed. In addition to the above tests, only in patients withulcers, Gram-stained smears and cultures from ulcer base
specimens were examined for the presence of Haemophilus
ducreyi and Giemsa-stained ulcer smears were examined for
multinucleated giant cells for the detection of herpes pro-
genitalis. (Detailed results of laboratory investigations, i.e.,
the presence of individual etiological agents, are presented
in a separate communication.15)
Every symptomatic patient was managed on the basis of
algorithms of the syndromic approach recommended by
NACO, India, after carrying out risk assessment.11 However,
keeping in view the literacy status and lack of knowledge of
the study groups, it was not always successful. The patients
were offered specific treatment at their follow-up visits on
the basis of their laboratory reports.
Statistical methods
Epi Info version 6.04d (January 2001) software, developed by
the WHO, was used for data entry and analysis. The Chi-
square test was applied to compare proportions in rural and
urban women and also in the different groups, and p-values
were calculated. The sensitivity and specificity of the dif-
ferent approaches of management were also calculated.
Results
Study population
The women ranged in age from 14 to 70 years and most of
them (89.8%) belonged to the reproductive age group. The
most predominant age group was 14—25 years (52.9%), fol-
lowed by 26—35 years (36.9%), 36—45 years (7.8%), 46—55
years (1.9%), and 56—70 years (0.5%). All the groups had a
similar distribution of ages, with the exception of group III,
where 72% of the women were in the 14—25 years age group.
In the rural clinics, there was higher representation of
women in the 14—25 years age group than in the urban
clinics.
Most of the patients were from the low-income group
(51.5% urban, 49.3% rural) and were illiterate (38.9% urban,
30.8% rural); 77.4% were Hindu upper caste.
Many were not using any contraceptive method (63.3%
urban, 59.8% rural), and knowledge about HIV/AIDS was nil in
49.8% urban and 51.9% rural women. Past history of RTIs/STIs
was 63.4% in urban and 54.4% in rural women.
Presenting complaints
Overall, self-reporting of morbidity (Table 1) was 65.0%.
Group I was 100% symptomatic. In group II, 72.9% (68.8%
urban vs.77.3% rural, p < 0.02) had symptoms and in group
III, 70.3% (74.3% urban vs. 66.2% rural, p < 0.001) had symp-
toms. Most of the women complained of vaginal discharge
(VD), either singly or in combination with other symptoms
like lower abdominal pain/low backache (LAP) not related to
menstruation, redness and itching of the vulva, and dyspar-
eunia. LAP was the only symptom in 5.8% cases. A total of
75.5% of women presented with more than one symptom, the
most prominent combination being some type of VD and LAP
(total 86.1%, urban 87.3%, rural 84.9%). Only 6.3% (4.9%
urban, 7.7% rural) had redness and itching of the vulva in
addition to this combination. A few women (1.6%; 1.0% urban
Table 2 Clinical findings on vaginal examination in the study groups
Signs Total Group I Group II Group III Group IV
Urban Rural Total Urban Rural Total Urban Rural Total Urban Rural Total Urban Rural Total
VD 1323
(63.6)
1405
(69.9)
2728
(66.7)
539
(96.9)
535
(98.7)
1074
(97.8)
166
(52.4)
195
(64.1)
361
(58.1)
499
(63.2)
549
(71.0)
1048
(67.1)
119
(28.7)
126 (32.6) 245
(30.6)
GUD 8
(0.4)
10
(0.5)
18
(0.4)
5
(0.9)
2
(0.4)
7
(0.6)
0 2
(0.7)
2
(0.3)
2
(0.2)
4
(0.5)
6
(0.4)
1
(0.2)
2 (0.5) 3
(0.4)
No signs 748
(36.0)
596
(29.6)
1344
(32.9)
12
(2.2)
5
(0.9)
17
(1.5)
151
(47.6)
107
(35.2)
258
(41.5)
289
(36.6)
220
(28.5)
509
(32.6)
294
(71.0)
259
(66.9)
553
(69.0)
No. tested 2079 2011 4090 556 542 1098 317 304 621 790 773 1563 414 387 801
Results are n (%). Group I, symptomatic; group II, bad obstetric history/infertility; group III, antenatal clinic attendees; group IV, control group; VD, vaginal discharge (mucoid/frothy yellowish-
green/curd-like/purulent); GUD, genital ulcer disease.
Table 1 Self-reporting of morbidity in the study groups
Complaints Total Group I Group II Group III Group IV
Urban Rural Total Urban Rural Total Urban Rural Total Urban Rural Total Urban Rural Total
VD only 246 (18.0) 213 (16.5) 459 (17.3) 104 (18.6) 96 (17.6) 200 (18.1) 40 (18.3) 29 (12.3) 69 (15.2) 102 (17.4) 88 (17.2) 190 (17.3) - - -
LAP only 81 (5.9) 72 (5.6) 153 (5.8) 13 (2.3) 10 (1.8) 23 (2.1) 22 (10.1) 21 (8.9) 43 (9.5) 46 (7.8) 41 (8.0) 87 (7.9) - - -
Othera 18 (1.3) 21 (1.6) 39 (1.5) 6 (1.1) 8 (1.5) 14 (1.3) 1 (0.5) 6 (2.6) 7 (1.5) 11 (1.9) 7 (1.4) 18 (1.6) - - -
>1b 1018 (74.7) 988 (76.3) 2006 (75.5) 435 (78.0) 433 (79.2) 868 (78.6) 155 (71.1) 179 (76.2) 334 (73.7) 428 (72.9) 376 (73.4) 804 (73.2) - - -
Total 1363 (65.6) 1294 (64.3) 2657 (65.0) 558 (100) 547 (100) 1105 (100) 218 (68.8) 235 (77.3) 453 (72.9) 587 (74.3) 512 (66.2) 1099 (70.3) - - -
No. tested 2079 2011 4090 558 547 1105 317 304 621 790 773 1563 414 387 801
Results are n (%). Group I, symptomatic; group II, bad obstetric history/infertility; group III, antenatal clinic attendees; group IV, control group; VD, vaginal discharge (mucoid/frothy yellowish-
green/curd-like/purulent); LAP, low abdominal pain/backache.
a Other = redness and itching of the vulva or dyspareunia alone.
b >1 = VD + LAP, or VD + redness and itching of the vulva, or VD + dyspareunia, or similar combinations with LAP.
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e356 K. Ray et al.and 2.3% rural) had only VD and redness and itching. The rest
of the combinations (6.0%) were negligible and are not worth
mentioning in detail. None of the women complained of
genital ulcers or genital wart growths.
Clinical examination
Vaginal examination
AVD was observed in 2728 out of 4090 (66.7%) women, 63.6%
in urban and 69.9% in rural women. The latter had signifi-
cantly more VD in comparison to their urban counterparts in
group II ( p < 0.01) and in group III ( p < 0.001). Overall, the
type of discharge was mucoid in 51.4%, curd-like in 39.7%,
yellowish-green in 7.4%, and purulent in 1.5%. No significant
difference was observed in the type of discharge between
urban and rural women. Genital ulcers were observed in only
18 women, eight urban (0.4%) and 10 (0.5%) rural (Table 2).
Clinically, a diagnosis of chancroid was made in five patients,
while a diagnosis of herpes progenitalis was made in 13.
Bimanual examination
Lower abdominal tenderness was observed in 13.5% of
women as a whole, 8.1% urban and 19.1% rural. Tenderness
in either or both fornices was observed in only 2.4% and pain
on moving the cervix in 2.6% of women.
Speculum examination
The predominant finding was cervical discharge, either singly
(52.4%) or in combination with a cervical growth like polyps
(0.4%). Cervical discharge as a single finding was seen more
often in rural women (58.9%) than in their urban counterparts
(46.1%) and the difference was highly significant ( p < 0.001).
However, cervical discharge in association with other findings
was observed in only 1.2% of urban and 5.1% of rural women.
Cervical erosion was detected in a total of 2.3% of women
(3.1% urban and 1.4% rural). Genital wart growths were
present in only 18 out of 4090 women (0.3% rural and 0.5%
urban). A total of 49.4% urban and 34.3% rural women had no
findings.
Syndromic diagnosis
Overall, 71.4% (94.6% in group I, 65.5% in group II, 70.6% in
group III, and 45.3% in group IV) had some STI syndrome, withTable 3 Syndromic diagnosis of STIs in the study groups
Syndrome Group I Group II Group I
Urban Rural Urban Rural Urban
Only GUD 1 (0.2) 1 (0.2) 0 0 0
Only VD 380 (68.1) 440 (80.4) 146 (46.0) 194 (63.8) 443 (56
Only PID 5 (0.9) 2 (0.4) 8 (2.5) 5 (1.6) 21 (2.7
GUD + VD 4 (0.7) 1 (0.2) 0 2 (0.7) 2 (0.2
VD + PID 139 (24.9) 72 (13.2) 31 (9.8) 21 (6.9) 60 (7.6
Total 529 (94.8) 516 (94.3) 185 (58.3) 222 (73.0) 526 (66
Total in
group (n)
558 547 317 304 790
Results are n (%). Group I, symptomatic; group II, bad obstetric history
group; STI, sexually transmitted infection; GUD, genital ulcer disease;
purulent); PID, pelvic inflammatory disease.variations in rural and urban women. Genital ulcer disease
(GUD) syndrome was observed alone in only four and in
combination with vaginal discharge syndrome (VDS) in 14.
VDS was predominantly observed, either singly or in combi-
nation with pelvic inflammatory disease (PID) syndrome and
GUD syndrome. A total of 93.8% in group I, 63.4% in group II,
68.8% in group III, and 39.7% in group IV had VDS, singly or in
combination with other syndromes. PID only was observed in
2.2% and in combination with VDS in 9.9%. The maximum
prevalence of PID was in group I (19.7%). Rural women as a
whole (74.8%) and in group II (73.0%) and group III (74.8%) had
a significantly higher proportion of STI syndromes than the
urban women ( p < 0.001; Table 3).
Etiological diagnosis
Laboratory investigations of RTIs/STIs in the study groups
revealed that overall 32.2% of women had some etiological
diagnosis (Table 4). The common diseases encountered in
etiological diagnosis included: (1) agents causing VDS: C.
albicans and species (22.6% urban, 17.5% rural), BV (4.2%
urban, 4.0% rural), T. vaginalis (2.0% urban, 2.3% rural), C.
trachomatis antigen (1.1% urban, 1.6% rural), N. gonorrhoeae
(0.6% urban, 0.7% rural); (2) agents causing GUD: HSV-2 (4.8%
urban, 6.8% rural), VDRL and TPHA positivity (1.0% urban,
1.1% rural); (3) other: hepatitis B surface antigen positivity
(1.1% urban, 1.6% rural), HIV seropositivity (0.2% urban, 0.1%
rural).
Comparison of patient complaints, syndromic
diagnosis, and etiological diagnosis in
symptomatic women in urban and rural areas
A comparison of patient complaints, syndromic diagnosis of
STIs, and etiological diagnosis (Figure 1) was made in the
different study groups. It was observed that in groups I, II,
III, and IV, respectively, 100%, 72.9% (68.8% urban and 77.3%
rural), 70.3% (74.3% urban and 66.2% rural), and 0% had some
STI symptoms, 94.6% (94.8% urban and 94.3% rural), 65.5%
(58.3% urban and 73.0% rural), 70.6% (66.6% urban and 74.8%
rural), and 45.3% (42.3% and 48.6%) had some syndrome, and
37.5% (42.6% urban and 32.2% rural), 32.2% (30.6% urban and
33.9% rural), 33.6% (36.1% urban and 31.0% rural), and 22.1%
(18.6% and 25.8%) had an etiological diagnosis. The sensitivityII Group IV Total with syndrome
Rural Urban Rural Urban Rural
1 (0.1) 0 1 (0.2) 1 (0.05) 3 (0.2)
.1) 532 (68.8) 107 (25.8) 163 (42.1) 1076 (51.8) 1329 (66.1)
) 6 (0.8) 29 (7.0) 15 (3.9) 63 (3.0) 28 (1.4)
) 3 (0.4) 1 (0.2) 1 (0.2) 7 (0.3) 7 (0.3)
) 36 (4.7) 38 (9.2) 8 (2.1) 268 (12.9) 137 (6.8)
.6) 578 (74.8) 175 (42.3) 188 (48.6) 1415 (68.1) 1504 (74.8)
773 414 387 2079 2011
/infertility; group III, antenatal clinic attendees; group IV, control
VD, vaginal discharge (mucoid/frothy yellowish-green/curd-like/
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Diagnosis of RTIs/STIs in women, Delhi e357of the syndromic approach for VDS in this studywas 93.8%, but
the specificity of this method in diagnosing vaginal discharge
was low at 37.5%.
Discussion
The present study revealed that VD was the most common
symptom reported by women, confirming previous stu-
dies.12—14 Overall, self-reporting of morbidity was 65.0%,
with VD as the main complaint, either singly or in combina-
tion with low backache, abdominal pain, itching vulva, or
dyspareunia. On clinical examination, VD was present in
66.7% of cases, confirming the data of a previous study.19
In this report, 12.7% of women complained of VD, up to 66.7%
were found to have abnormal VD on vaginal examination, and
52.8% had a cervical discharge on speculum examination. In
the present study, genital ulcers and genital warts were not
reported by the study subjects. This is an indication that
awareness of STIs and health-seeking behavior are inade-
quate in women, making them unable to relate their STI
symptoms accurately.
While a high proportion of women were diagnosed by the
syndromic approach, their total infection load as determined
by etiological diagnosis was quite low. This could mean that
RTIs/STIs are being over-diagnosed by the investigating phy-
sician and even that physiological discharge was misinter-
preted as pathological. Therefore, the sensitivity of the
syndromic approach for VDS in this study was high, but the
specificity of this method in diagnosing VD was low, as
reported previously.14 It is not possible to comment on the
other minor syndromes as well as mixed syndromes from this
data; this may be considered as one of the limitations of the
study.
A community-based survey of 3000 women, randomly
sampled from a population in Goa, India, was carried out
in 2001—2003.20 In this study, psychosocial factors instead of
etiological agents of RTIs/STIs were found to have the stron-
gest association with the complaint of VD. It was recom-
mended that syndromic management algorithms be refined
so that women with complaints that are non-infectious in
etiology are offered psychosocial interventions. Another
possibility for the disagreement between syndromic and
laboratory diagnosis could be that the laboratory techniques
for diagnosis are not available early enough.21 Also, there is a
need for more sensitive techniques like PCR for the diagnosis
of these infections.
The lower detection rate of RTIs/STIs by etiological
approach than the syndromic approach in the present study
could be real or could be due to self-medication, which is
rampant in the community. This is due to the availability of
‘over-the-counter’ antimicrobials and requires further
research in tertiary care health institutions to compare rates.
Non-availability of nucleic acid-based tests like PCR, as
mentioned above, could also have resulted in the lower
detection by laboratory methods; this is another limitation
of this study.
A Chinese study22 attempted to validate diagnostic algo-
rithms for syndromic management of STIs with laboratory
diagnostic support. The authors reported that the specificity
and positive predictive value of syndromic management of
VD were not satisfactory. In contrast to this report,22 a
community-based study in India in 812 women revealed that
Figure 1 Comparison of symptoms, syndromic diagnosis, and
etiological diagnosis.
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high sensitivity (80.5%) and high positive predictive value
(81.3%), but low specificity (48.6%) and low negative pre-
dictive value (47.5%).23 The level of agreement was found to
be fair (Kappa = 0.28, 95% confidence interval = 0.20—0.36).
The authors recommended a revision of history-based syn-
dromic protocols.
A study was undertaken in Entebbe, Uganda to measure
the prevalence of RTIs during pregnancy and to evaluate the
current syndromic diagnosis and management approach in
effectively targeting BV and T. vaginalis.24 It was observed
that the sensitivity of syndromicmanagement in detecting BV
was 50.0% and for T. vaginalis was 66.7%.
STD syndromic treatment impacts very little in reducing
genital HIV shedding, underscoring the need for appropriate
validation of STD syndromic diagnosis and management to
control heterosexual transmission of HIV.25
The present study did not observe any association
between the presenting symptoms, syndromic diagnosis,
and etiological diagnosis, and thus the syndromic approach
in VDS may not be effective, as reported earlier.12—14,26 A
high rate of over-treatment was observed in the study
groups, in contrast to a previous study reporting the chances
of over-treatment for VD and PID as only 16% and 15%,
respectively.23 Over-treatment carries both financial and
social costs, the latter in potentially exposing women mis-
diagnosed as having some STI to threats of domestic disrup-
tion or even violence.14
It is interesting to note that a higher proportion of rural
women than urban women had some STI syndrome. This
indicates that the urban women had a greater knowledge
regarding STIs and that accessibility tomedicines in the urban
areas was better. However, the significantly higher etiologi-
cal diagnosis in the urban women probably indicates impro-
per and indiscriminate use of antimicrobials.A significant proportion of asymptomatic women in groups
II, III, and IV harbored etiological agents of RTIs/STIs and
were unfortunately not covered under syndromic manage-
ment, as emphasized earlier.10 In a study in the red light area
of Surat, India, the performance of the Indian recommended
treatment guidelines for VDS and GUD against etiological
diagnosis was observed to be poor.19 It was concluded that
syndromic case management was missing a large number of
the asymptomatic cases and was providing treatment in the
absence of disease.
There remains an urgent need for the development of an
affordable, rapid, and effective diagnostic technique to
improve the detection of RTIs/STIs in women in resource-
poor settings. This may prevent sequelae and reduce trans-
mission of these infections.27—29
Conclusions
This study highlights a wide variation between self-reporting
of morbidity, syndromic-based diagnosis, and etiological-
based diagnosis in women from rural and urban locations
in different parts of Delhi. This may affect the assessment of
the utility of the syndromic approach for STI case manage-
ment countrywide. This data calls for an early appraisal and
review of the diagnostic policy by national authorities, and
the introduction and/or strengthening of laboratory facil-
ities, especially at the peripheral level. Tertiary care centers
can periodically assess the burden of STIs in the community
and assess antimicrobial resistance patterns using laboratory
tests to determine strategies. This may allow the overuse/
abuse of antimicrobials to be avoided and prevent the devel-
opment of antimicrobial resistance.
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